Ignite Creation Date:
2025-12-24 @ 4:13 PM
Ignite Modification Date:
2026-03-11 @ 12:56 AM
Study NCT ID:
NCT01850966
Status:
COMPLETED
Last Update Posted:
2018-11-05
First Post:
2013-05-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid Arthritis
Sponsor:
Eisai Co., Ltd.
Organization:
Study Overview
Official Title:
Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid Arthritis
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To investigate the safety and efficacy of the administration of Iguratimod (CRM01T) for 52 weeks in patients with rheumatoid arthritis in clinical practice
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: